Sustained Delivery of IL-1Ra from Pluronic F127-Based Thermosensitive Gel Prolongs its Therapeutic Potentials

Interleukin-1 Receptor Antagonist: A New Therapy for Type 2 Diabetes Mellitus

(2012) Muhammad Sajid Hamid Akash et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Alternate therapy of Type 2 diabetes mellitus (T2DM) with Nigella (Ranunculaceae)

(2011) M. S. H. Akash   Journal of Medicinal Plants Research

DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles

(2010) Yong Zhang et al.   AAPS Journal

Biodistribution, pharmacokinetics and metabolism of interleukin-1 receptor antagonist (IL-1RA) using [18F]-IL1RA and PET imaging in rats

(2010) C Cawthorne et al.   BRITISH JOURNAL OF PHARMACOLOGY

Blocking interleukin-1β in acute and chronic autoinflammatory diseases

(2010) C. A. Dinarello   JOURNAL OF INTERNAL MEDICINE

Blockade of interleukin 1 in type 1 diabetes mellitus

(2010) Thomas Mandrup-Poulsen et al.   Nature Reviews Endocrinology

Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction

(2009) Jan A. Ehses et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs

(2008) L. J. Holt et al.   PROTEIN ENGINEERING DESIGN & SELECTION